Notable Recent Publications

These are some recent publications which give a flavour of the research from the Barclay lab. For a complete list of publications, please see below.

Jason S. Long, Efstathios S. Giotis, Olivier Moncorgé, Rebecca Frise, Bhakti Mistry, Joe James, Mireille Morisson, Munir Iqbal, Alain Vignal, Michael A. Skinner & Wendy S. Barclay

This paper identified a key factor that explained why the polymerases from avian influenza viruses are restricted in humans.  For more, please see the associated .

See our latest ANP32 papers here: ,, .

Daniel H. Goldhill, Aartjan J. W. te Velthuis, Robert A. Fletcher, Pinky Langat, Maria Zambon, Angie Lackenby & Wendy S. Barclay

This paper showed how influenza could evolve resistance to favipiravir, an antiviral that may be used to treat influenza. The residue that mutated to give resistance was highly conserved suggesting that the mechanism of resistance may be applicable to other RNA viruses.

Hui Li*, Konrad C. Bradley*, Jason S. Long, Rebecca Frise, Jonathan W. Ashcroft, Lorian C. Hartgroves, Holly Shelton, Spyridon Makris, Cecilia Johansson, Bin Cao & Wendy S. Barclay

Why do avian influenza viruses like H5N1 cause such severe disease in humans? This paper demonstrated that H5N1 viruses replicate better than human viruses in myeloid cells from mice leading to a cytokine storm and more severe disease.

Citation

BibTex format

@article{Singanayagam:2017:10.1016/S1473-3099(17)30638-2,
author = {Singanayagam, A and Zambon, M and Lalvani, A and Barclay, W},
doi = {10.1016/S1473-3099(17)30638-2},
journal = {Lancet Infectious Diseases},
pages = {1235--1236},
title = {Can defective interfering RNAs affect the live attenuated influenza vaccine? Reply},
url = {http://dx.doi.org/10.1016/S1473-3099(17)30638-2},
volume = {17},
year = {2017}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AU  - Singanayagam,A
AU  - Zambon,M
AU  - Lalvani,A
AU  - Barclay,W
DO  - 10.1016/S1473-3099(17)30638-2
EP  - 1236
PY  - 2017///
SN  - 1473-3099
SP  - 1235
TI  - Can defective interfering RNAs affect the live attenuated influenza vaccine? Reply
T2  - Lancet Infectious Diseases
UR  - http://dx.doi.org/10.1016/S1473-3099(17)30638-2
VL  - 17
ER  -
Download

Contact us

For any enquiries related to this group, please contact:

Professor Wendy Barclay
Chair in Influenza Virology 
+44 (020) 7594 5035
w.barclay@imperial.ac.uk